Tweet
New York Times |
Pharmacy Deal Heralds Changed Landscape for Hepatitis Drugs New York Times In a sign that price competition may take hold for hepatitis C drugs, the nation's largest manager of prescriptions will require all patients to use AbbVie's newly approved treatment rather than two widely used medicines from its rival Gilead Sciences. Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatmentReuters Express Scripts Shuns Gilead in Hepatitis C Deal With AbbVieBusinessweek New Hepatitis C Drug Gets Helping HandWall Street Journal STLtoday.com -CNBC -Seeking Alpha all 33 news articles » |
More...